glp-1 united healthcare Weight Loss Treatment NutraBetic GLP-1 Companion with GlucoVantage

Landmark cardiovascular outcome trials (CVOTs) provided the first consistent signals of renal benefit with GLP-1RAs, largely driven by exploratory composite kidney endpoints and reductions in new or worsening albuminuria (e.g., LEADER, REWIND, SUSTAIN-6, EXSCEL, and ELIXA

Tirzepatide is clearly more effective for maximum weight loss due to its dual receptor mechanism

PubMed Central PMCID: PMC9821052

With so many different terms for injectables, it helps to understand the difference between semaglutide and tirzepatide, or Ozempic and Wegovy

Mouhammad ZA, Vohra R, Horwitz A, Thein AS, Rovelt J, Cvenkel B, Williams PA, Azuara-Blanco A, Kolko M (2022) Glucagon-Like Peptide 1 Receptor Agonists -Potential Game Changers in the Treatment of Glaucoma